These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 7716922)

  • 1. [Isolation of human B-cells, specific for viral peptides, using magnetic spheres].
    Sidorova EV; Borisova TK; Rozen A
    Vopr Virusol; 1994; 39(6):272-4. PubMed ID: 7716922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human monoclonal antibodies to viral peptides.
    Sidorova E; Borisova T; Lyakisheva L; Rosen A
    Hum Antibodies; 1997; 8(2):65-9. PubMed ID: 9289390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
    Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
    Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Human monoclonal antibodies to synthetic viral peptides].
    Borisova TK; Rosen A; Sidorova EV
    Vopr Virusol; 1999; 44(4):172-4. PubMed ID: 10500986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins.
    Sample C; Parker B
    Virology; 1994 Dec; 205(2):534-9. PubMed ID: 7975254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I.
    Sabbatini A; Bombardieri S; Migliorini P
    Eur J Immunol; 1993 May; 23(5):1146-52. PubMed ID: 8386666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
    Sauder C; Haiss P; Grässer FA; Zimber-Strobl U; Mueller-Lantzsch N
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():3067-79. PubMed ID: 7964616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids.
    Contreras-Brodin BA; Anvret M; Imreh S; Altiok E; Klein G; Masucci MG
    J Gen Virol; 1991 Dec; 72 ( Pt 12)():3025-33. PubMed ID: 1662694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of two Epstein-Barr virus epitopes restricted by HLA-B7.
    Hill A; Worth A; Elliott T; Rowland-Jones S; Brooks J; Rickinson A; McMichael A
    Eur J Immunol; 1995 Jan; 25(1):18-24. PubMed ID: 7531143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of major histocompatibility complex class I interaction with Epstein-Barr virus and human immunodeficiency virus peptides by elevation of membrane H-2 and HLA in peptide loading-deficient cells.
    Stuber G; Modrow S; Höglund P; Franksson L; Elvin J; Wolf H; Kärre K; Klein G
    Eur J Immunol; 1992 Oct; 22(10):2697-703. PubMed ID: 1327802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen.
    Rhodes G; Carson DA; Valbracht J; Houghten R; Vaughan JH
    J Immunol; 1985 Jan; 134(1):211-6. PubMed ID: 2981091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resting B-cells, EBV-infected B-blasts and established lymphoblastoid cell lines differ in their Rb, p53 and EBNA-5 expression patterns.
    Szekely L; Pokrovskaja K; Jiang WQ; Selivanova G; Löwbeer M; Ringertz N; Wiman KG; Klein G
    Oncogene; 1995 May; 10(9):1869-74. PubMed ID: 7753563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delineation of a 16 amino acid sequence that forms a core DNA recognition motif in the Epstein-Barr virus EBNA-1 protein.
    Chen MR; Zong J; Hayward SD
    Virology; 1994 Dec; 205(2):486-95. PubMed ID: 7975250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical and mutational analysis of the putative bZIP domain of Epstein-Barr virus EBNA 3C.
    West MJ; Webb HM; Sinclair AJ; Woolfson DN
    J Virol; 2004 Sep; 78(17):9431-45. PubMed ID: 15308737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 and hsp70 proteins after exposure to heat shock or cell density congestion.
    Szekely L; Jiang WQ; Pokrovskaja K; Wiman KG; Klein G; Ringertz N
    J Gen Virol; 1995 Oct; 76 ( Pt 10)():2423-32. PubMed ID: 7595346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-encoded EBNA-5 binds to Epstein-Barr virus-induced Fte1/S3a protein.
    Kashuba E; Yurchenko M; Szirak K; Stahl J; Klein G; Szekely L
    Exp Cell Res; 2005 Feb; 303(1):47-55. PubMed ID: 15572026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human monoclonal antibodies to MN-24 peptide of gp 120 HIV-1.
    Sidorova E
    Hum Antibodies; 1999; 9(2):107-10. PubMed ID: 10405831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody.
    Maunders MJ; Petti L; Rowe M
    J Gen Virol; 1994 Apr; 75 ( Pt 4)():769-78. PubMed ID: 7512118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide.
    Farrell CJ; Lee JM; Shin EC; Cebrat M; Cole PA; Hayward SD
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4625-30. PubMed ID: 15070768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear DNA-binding proteins determined by the Epstein-Barr virus-related simian lymphotropic herpesviruses H. gorilla, H. pan, H. pongo and H. papio.
    Dillner J; Rabin H; Letvin N; Henle W; Henle G; Klein G
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1587-96. PubMed ID: 2438377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.